Mozart Therapeutics Completes Ph1a Study in Healthy Adults; Data Shows MTX-101 is Well Tolerated and Selectively Activates CD8 Treg

Mozart Therapeutics Completes Ph1a Study in Healthy Adults; Data Shows MTX-101 is Well Tolerated and Selectively Activates CD8 Treg

3 days ago Australia Leave a comment 0 Views

Enrollment of Patients with Autoimmune Disease in Phase 1b Study has Begun SEATTLE, March 17, 2025 /PRNewswire/ — Mozart Therapeutics, the leading developer of CD8 Treg modulators for the treatment of autoimmune disease, today announce the successful completion of their Phase 1a study of…
Read more

View More Detail

Check Also

Strange foam and dead fish wash onto 2 Australian beaches as surfers fall sick

Strange foam and dead fish wash onto 2 Australian beaches as surfers fall sick

An Australian state has closed two beaches after surfers reported feeling unwell while dead fish …

Vickerman comfortable with ref call that enraged Hawks

Vickerman comfortable with ref call that enraged Hawks

Justin Tatum was frustrated by the referees in game three of the NBL championship series, …

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© Copyright 2025, All Rights Reserved